Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and …

Dec 20, 2024 · Novo Nordisk's no good, very bad day. Originally designed to treat patients with diabetes, GLP-1 drugs like Novo's Ozempic and Lilly's Zepbound have taken on a new role in …

CouponFollow Extension

8%
OFF

Why Novo Nordisk Stock Got Destroyed Today, But Eli Lilly And

4 weeks from now

As of 11:05 a.m. ET, Novo Nordisk stock is down a disheartening 20.8%, while both Lilly and Viking stocks are up 4.4% apiece. Start Your Mornings Smarter! Wake up with Breakfast news …

msn.com

27%
OFF

NVO News Today | Why Did Novo Nordisk A/S Stock Go Down …

4 weeks from now

5 days ago · Eli Lilly, Novo Nordisk Stocks Rise After One Just Hit a Landmark. December 23, 2024 | barrons.com. Novo Nordisk's 27% drop was market overreaction, analysts say. ... Why …

marketbeat.com

6%
OFF

Why Novo Nordisk Stock Fell While Eli Lilly And Viking ... - MSN

4 weeks from now

Novo Nordisk's stock price declined by nearly 6% on the day, while the two gainers rose 3.4% and 0.7%, respectively. Side effects reported for investigational drug

msn.com

18%
OFF

Novo Nordisk Stock Crashes 18% After New Obesity Drug Misses …

4 weeks from now

Dec 20, 2024 · The bad news sent Novo Nordisk stock down 17.8% to 85. Shares have been falling since midyear. Eli Lilly stock rose 1.4% to 767.76, while Viking Therapeutics shares ran …

investors.com

5%
OFF

Novo Nordisk Stock Plunges After Trial For New Weight Loss Drug ...

4 weeks from now

Dec 20, 2024 · Eli Lilly, a competitor in the market for GLP-1 weight loss drugs, was up about 5%. ... Novo Nordisk's stock suffered its biggest one-day slide on record after its latest obesity drug …

businessinsider.com

27%
OFF

Novo Nordisk’s 27% Drop On Friday Was A Market ... - MarketWatch

4 weeks from now

Dec 23, 2024 · Novo Nordisk’s shares recovered some ground on Monday after a 27% slump on Friday in response to an underwhelming set of results from a Phase III trial of its new weight …

marketwatch.com

7%
OFF

Novo Nordisk Stock Falls After Biden Slams Drugmaker For ...

4 weeks from now

Jul 2, 2024 · Novo Nordisk stock fell as low as 139.03 before paring losses to down 1.7% at 142.99, back above the 21-day moving average. Eli Lilly stock slumped 0.8% to 906.87. LLY …

investors.com

32%
OFF

Why Novo Nordisk And Eli Lilly Stocks Slipped Today

4 weeks from now

Feb 27, 2024 · The arrival of a potential new rival in an important product category dinged the share prices of pharmaceutical companies Novo Nordisk (NVO-0.32%) and Eli Lilly (LLY …

fool.com

20%
OFF

Novo Nordisk Shares Plunge 20% After Disappointing Trial Results; …

4 weeks from now

Dec 20, 2024 · Shares of Novo Nordisk plummeted roughly 20% on Friday. The fall comes after the Danish pharmaceutical giant reported results in a late-stage trial for its experimental …

nbcchicago.com

40%
OFF

What's Happening With Novo Nordisk Stock? - Nasdaq

4 weeks from now

6 days ago · Novo Nordisk ADR (NYSE: NVO) currently trades at $85 per share, more than 40% below its peak level of over $145 seen in June of this year. In contrast, its closest peer, Eli Lilly …

nasdaq.com

28%
OFF

Better Buy: Eli Lilly Vs. Novo Nordisk. The Answer Is Becoming ...

4 weeks from now

6 days ago · Shares of Novo got absolutely destroyed on the CagriSema news, with the stock cratering as much as 28% just in one day. Lilly is more than just a weight-loss company

fool.com

8%
OFF

Why Novo Nordisk Stock Got Destroyed Today, But Eli Lilly

4 weeks from now

Dec 20, 2024 · As of 11:05 a.m. ET, Novo Nordisk stock is down a disheartening 20.8%, while both Lilly and Viking stocks are up 4.4% apiece. Originally designed to treat patients with …

sharewise.com

34%
OFF

Why Novo Nordisk Stock Got Destroyed Today, But Eli Lilly And …

4 weeks from now

Today's sell-off in Novo Nordisk may be the buying opportunity you've been waiting for. Bad news for Novo Nordisk (NVO -17.34%) Friday was good news for Eli Lilly (LLY 4.92%) and Viking …

reportify.cc

FAQs about Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and … Coupon?

Should you buy Novo Nordisk & Lilly?

As of 11:05 a.m. ET, Novo Nordisk stock is down a disheartening 20.8%, while both Lilly and Viking stocks are up 4.4% apiece. Originally designed to treat patients with diabetes, GLP-1 drugs like Novo's Ozempic and Lilly's Zepbound have taken on a new role in society as the go-to treatment for obesity, and for easy weight loss, generally. ...

Does Novo Nordisk have good news for Eli Lilly and vktx?

Bad news for Novo Nordisk(NYSE: NVO) Friday was good news for Eli Lilly(NYSE: LLY) and Viking Therapeutics(NASDAQ: VKTX), its two main rivals in the field of weight loss drugs. ...

Will Eli Lilly and Novo Nordisk own the top weight loss drugs?

Don't assume that Eli Lilly and Novo Nordisk will own the top weight loss drugs on the market in the future. It's not just the overall weight loss that may ultimately matter to patients; it might be the treatment with the fewest side effects that ends up winning the majority of market share. ...

Why did Novo Nordisk stock tank?

Novo Nordisk's stock tanked after a highly anticipated drug trial disappointed. The study showed its new obesity drug helped people lose less weight than expected. Eli Lilly, a competitor in the market for GLP-1 weight loss drugs, was up about 5%. ...

Is Novo Nordisk a good stock to buy now?

While Novo Nordisk is probably the better weight-management stock, a more diverse product lineup and development pipeline make Eli Lilly the better overall pharmaceutical business. A more reasonable valuation makes me want to call Novo Nordisk the better buy now, but that probably isn't the best course of action. ...

Why did Novo Nordisk pull out of monlunabant?

No matter how efficacious a drug may be, if it produces a series of worrying side effects it has quite a reduced chance of winning approval from regulators. So with Novo Nordisk's effective "back to the drawing board," news of monlunabant, investors cautiously pulled out of the Denmark-based company to the benefit of Eli Lilly and Viking. ...